海王生物：2025年半年度净利润约3168万元，同比下降30.23%

Core Viewpoint - Haiwang Biological (SZ 000078) reported a decline in both revenue and net profit for the first half of 2025, indicating challenges in its financial performance [1] Financial Performance - The company's revenue for the first half of 2025 was approximately 14.312 billion yuan, representing a year-on-year decrease of 13.95% [1] - The net profit attributable to shareholders was around 31.68 million yuan, down 30.23% compared to the previous year [1] - Basic earnings per share were 0.012 yuan, reflecting a decrease of 30.64% year-on-year [1]